SEC Form 4 · accession 0001179110-15-010897
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Jul 1, 2015
Accepted (ET)
Jul 6, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2015 | M | 15,000 | $23.755 | A | 156,422 | D | |
| Common StockF3 | Jul 1, 2015 | S | 6,830 | $115.9447 | D | 149,592 | D | |
| Common StockF4 | Jul 1, 2015 | S | 4,907 | $117.0062 | D | 144,685 | D | |
| Common StockF5 | Jul 1, 2015 | S | 3,263 | $117.9243 | D | 141,422 | D | |
| Common StockF6 | Jul 1, 2015 | S | 765 | $115.9139 | D | 140,657 | D | |
| Common StockF7 | Jul 1, 2015 | S | 700 | $116.9029 | D | 139,957 | D | |
| Common StockF8 | Jul 1, 2015 | S | 535 | $117.9456 | D | 139,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $23.755 | Jul 1, 2015 | M | 15,000 | D | — | Jan 28, 2020 | Common Stock | 15,000 | 16,375 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $115.4991 to $116.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $116.5456 to $117.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $117.60 to $118.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $115.46 to $116.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F7Sale prices reported for the transactions reported here range from $116.59 to $117.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F8Sale prices reported for the transactions reported here range from $117.61 to $118.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.